Loading the page.
Proteins/UNIPROT:Q04771
Bone morphogenetic protein (BMP) type I receptor that is involved in a wide variety of biological processes, including bone, heart, cartilage, nervous, and reproductive system development and regulation. As a type I receptor, forms heterotetrameric receptor complexes with the type II receptors AMHR2, ACVR2A or ACVR2B. Upon binding of ligands such as BMP7 or GDF2/BMP9 to the heteromeric complexes, type II receptors transphosphorylate ACVR1 intracellular domain. In turn, ACVR1 kinase domain is activated and subsequently phosphorylates SMAD1/5/8 proteins that transduce the signal. In addition to its role in mediating BMP pathway-specific signaling, suppresses TGFbeta/activin pathway signaling by interfering with the binding of activin to its type II receptor. Besides canonical SMAD signaling, can activate non-canonical pathways such as p38 mitogen-activated protein kinases/MAPKs (By similarity). May promote the expression of HAMP, potentially via its interaction with BMP6 (By similarity)..
Function from UniProtKB (Q04771), read 2026-09-23. CC BY 4.0.
Curated compounds routed: 0
1 row
142 statements
142 statements · 4 reference databases · Subject: ACVR1 · Sources: gene ontology, Hetionet, UniProt, WikiPathways
2 reactions
10 names
Resolves to: ACVR1
Rhea RHEA:18673CC BY 4.0Reference data
L-threonyl-[receptor-protein]+ATP(4-)O-phospho-L-threonyl-[receptor-protein]+ADP(3-)+hydron
Catalysed by BMPR1B or ACVR2A or BMPR1A or ACVR1B or TGFBR1 or ACVRL1 or TGFBR2 or ACVR1 or ACVR2B or BMPR2 or AMHR2 or ACVR1C
Reaction pageLeft to rightBalance undeterminable
Rhea RHEA:44880CC BY 4.0Reference data